iNOS 选择性抑制剂在癌症预防中的应用：前景与进展。
iNOS-selective inhibitors for cancer prevention: promise and progress.
机构信息
Center for Cancer Prevention & Drug Development, Medical Oncology, Department of Medicine, PCS Oklahoma Cancer Center, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA.
出版信息
Future Med Chem. 2012 Nov;4(17):2193-204. doi: 10.4155/fmc.12.168.
Abstract
Nitric oxide (NO) is involved in various physiological functions and its role in tumorigenesis has been well studied. A large majority of human and experimental tumors appear to progress owing to NO resulting from iNOS, further stimulated by proinflammatory cytokines. Conversely, in some cases, NO is associated with induction of apoptosis and tumor regression. This dichotomy of NO is largely explained by the complexity of signaling pathways in tumor cells, which respond to NO very differently depending on its concentration. In addition, NO alters many signaling pathways through chemical modifications, such as the addition of S-nitrosothiols and nitrosotyrosine to target proteins altering various biological pathways. Hence, iNOS inhibitors are designed and developed to inhibit various organ site cancers including the colon. Here, we review iNOS expression, generation of NO, involvement of NO in altering signaling pathways, and iNOS select inhibitors and their possible use for the prevention and treatment of various cancers.
摘要
一氧化氮（NO）参与各种生理功能，其在肿瘤发生中的作用已得到充分研究。大多数人类和实验性肿瘤似乎由于 iNOS 产生的 NO 而进展，进一步受到促炎细胞因子的刺激。相反，在某些情况下，NO 与细胞凋亡和肿瘤消退有关。NO 的这种二分法在很大程度上可以通过肿瘤细胞信号通路的复杂性来解释，这些信号通路根据 NO 的浓度而对 NO 的反应非常不同。此外，NO 通过化学修饰改变许多信号通路，例如将 S-亚硝基硫醇和硝基酪氨酸添加到靶蛋白中，从而改变各种生物途径。因此，设计和开发了 iNOS 抑制剂来抑制包括结肠在内的各种器官部位的癌症。在这里，我们回顾了 iNOS 的表达、NO 的产生、NO 在改变信号通路中的作用以及 iNOS 选择性抑制剂及其在预防和治疗各种癌症中的可能用途。
相似文献
1
iNOS-selective inhibitors for cancer prevention: promise and progress.iNOS 选择性抑制剂在癌症预防中的应用：前景与进展。
Future Med Chem. 2012 Nov;4(17):2193-204. doi: 10.4155/fmc.12.168.
2
Nitric oxide signaling in colon cancer chemoprevention.一氧化氮信号传导在结肠癌化学预防中的作用
Mutat Res. 2004 Nov 2;555(1-2):107-19. doi: 10.1016/j.mrfmmm.2004.05.022.
3
Tumor-generated nitric oxide as an antagonist of photodynamic therapy.肿瘤产生的一氧化氮作为光动力疗法的拮抗剂。
Photochem Photobiol Sci. 2015 Aug;14(8):1425-32. doi: 10.1039/c4pp00470a. Epub 2015 Feb 23.
4
High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.高一氧化氮产量继发于诱导型一氧化氮合酶的表达，对于调控结肠癌干细胞的肿瘤起始特性是必需的。
J Pathol. 2015 Aug;236(4):479-90. doi: 10.1002/path.4545. Epub 2015 May 12.
5
Neuropeptide (calcitonin gene-related peptide) induction of nitric oxide in human keratinocytes in vitro.
J Invest Dermatol. 2006 Sep;126(9):1994-2001. doi: 10.1038/sj.jid.5700349. Epub 2006 May 18.
6
Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms.调节诱导型一氧化氮合酶的药理学策略：神经退行性与神经保护机制
Neurochem Int. 2006 Jul;49(2):170-82. doi: 10.1016/j.neuint.2006.04.010. Epub 2006 Jun 12.
7
Nitric oxide associated with iNOS expression inhibits acetylcholinesterase activity and induces memory impairment during acute hypobaric hypoxia.与诱导型一氧化氮合酶表达相关的一氧化氮在急性低压缺氧期间会抑制乙酰胆碱酯酶活性并导致记忆障碍。
Brain Res. 2008 Sep 16;1230:138-49. doi: 10.1016/j.brainres.2008.06.081. Epub 2008 Jun 28.
8
Small molecule inhibitors and stimulators of inducible nitric oxide synthase in cancer cells from natural origin (phytochemicals, marine compounds, antibiotics).天然来源的诱导型一氧化氮合酶小分子抑制剂和刺激剂在癌细胞中的作用（植物化学物质、海洋化合物、抗生素）。
Biochem Pharmacol. 2020 Jun;176:113792. doi: 10.1016/j.bcp.2020.113792. Epub 2020 Jan 9.
9
Nitric oxide: state of the art in drug design.一氧化氮：药物设计的最新进展。
Curr Med Chem. 2012;19(3):386-405. doi: 10.2174/092986712803414321.
10
Ghrelin suppression of Helicobacter pylori-induced S-nitrosylation-dependent Akt inactivation exerts modulatory influence on gastric mucin synthesis.生长激素释放肽抑制幽门螺杆菌诱导的 S-亚硝化依赖的 Akt 失活对胃黏液合成发挥调节作用。
Inflammopharmacology. 2011 Apr;19(2):89-97. doi: 10.1007/s10787-011-0078-4. Epub 2011 Jan 29.
引用本文的文献
1
The evolution of S-nitrosylation detection methodology and the role of protein S-nitrosylation in various cancers.S-亚硝基化检测方法的演变以及蛋白质S-亚硝基化在各种癌症中的作用。
Cancer Cell Int. 2024 Dec 19;24(1):408. doi: 10.1186/s12935-024-03568-y.
2
In Vitro and In Vivo Antitumor Activities of Isothiourea and Cinnamic Acid Derivative with NOS/MCT Inhibitory Effect.具有一氧化氮合酶/单羧酸转运体抑制作用的异硫脲和肉桂酸衍生物的体外和体内抗肿瘤活性
Bull Exp Biol Med. 2024 Nov;178(1):68-74. doi: 10.1007/s10517-024-06284-9. Epub 2024 Nov 22.
3
In Vitro Cytotoxic Potential and In Vivo Antitumor Effects of NOS/PDK-Inhibitor T1084.体外细胞毒性潜力和 NOS/PDK 抑制剂 T1084 的体内抗肿瘤作用。
Int J Mol Sci. 2024 Sep 8;25(17):9711. doi: 10.3390/ijms25179711.
4
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection.调节一氧化氮：对细胞毒性和细胞保护的影响
Antioxidants (Basel). 2024 Apr 23;13(5):504. doi: 10.3390/antiox13050504.
5
Daeshiho-tang attenuates inflammatory response and oxidative stress in LPS-stimulated macrophages by regulating TLR4/MyD88, NF-κB, MAPK, and Nrf2/HO-1 pathways.大枣四逆汤通过调控 TLR4/MyD88、NF-κB、MAPK 和 Nrf2/HO-1 通路来减轻 LPS 刺激的巨噬细胞中的炎症反应和氧化应激。
Sci Rep. 2023 Nov 2;13(1):18891. doi: 10.1038/s41598-023-46033-y.
6
Anti-Inflammatory Activity of '-(3-(1H-indol-3-yl)benzylidene)-2-cyanoacetohydrazide Derivative via sGC-NO/Cytokine Pathway.“-(3-(1H-吲哚-3-基)亚苄基)-2-氰基乙酰肼衍生物通过sGC-NO/细胞因子途径的抗炎活性”
Pharmaceuticals (Basel). 2023 Oct 5;16(10):1415. doi: 10.3390/ph16101415.
7
Chlorogenic Acid Alleviates LPS-Induced Inflammation and Oxidative Stress by Modulating CD36/AMPK/PGC-1α in RAW264.7 Macrophages.绿原酸通过调控 RAW264.7 巨噬细胞中的 CD36/AMPK/PGC-1α 减轻 LPS 诱导的炎症和氧化应激。
Int J Mol Sci. 2023 Aug 31;24(17):13516. doi: 10.3390/ijms241713516.
8
Application of nano-radiosensitizers in combination cancer therapy.纳米放射增敏剂在联合癌症治疗中的应用。
Bioeng Transl Med. 2023 Feb 10;8(3):e10498. doi: 10.1002/btm2.10498. eCollection 2023 May.
9
Anti-Inflammatory Activity of Mulberry Leaf Flavonoids In Vitro and In Vivo.桑叶黄酮的体外和体内抗炎活性。
Int J Mol Sci. 2022 Jul 12;23(14):7694. doi: 10.3390/ijms23147694.
10
Houttuynia Essential Oil and its Self-Microemulsion Preparation Protect Against LPS-Induced Murine Mastitis by Restoring the Blood-Milk Barrier and Inhibiting Inflammation.鱼腥草精油及其自微乳制剂通过恢复血乳屏障和抑制炎症来防治 LPS 诱导的小鼠乳腺炎。
Front Immunol. 2022 Feb 18;13:842189. doi: 10.3389/fimmu.2022.842189. eCollection 2022.
本文引用的文献
1
Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action.NO 供体型阿司匹林在结肠癌细胞中诱导的蛋白硝化和亚硝化：与它的作用机制相关。
Exp Cell Res. 2011 Jun 10;317(10):1359-67. doi: 10.1016/j.yexcr.2011.03.001. Epub 2011 Mar 22.
2
S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells.死亡受体 Fas 的 S-亚硝基化促进癌细胞中 Fas 配体介导的细胞凋亡。
Gastroenterology. 2011 Jun;140(7):2009-18, 2018.e1-4. doi: 10.1053/j.gastro.2011.02.053. Epub 2011 Feb 24.
3
Estradiol-17beta stimulates specific receptor and endogenous nitric oxide-dependent dynamic endothelial protein S-nitrosylation: analysis of endothelial nitrosyl-proteome.雌二醇-17β刺激特异性受体和内源性一氧化氮依赖的动态内皮蛋白 S-亚硝酰化：内皮一氧化氮蛋白组分析。
Endocrinology. 2010 Aug;151(8):3874-87. doi: 10.1210/en.2009-1356. Epub 2010 Jun 2.
4
Nitric oxide donors: novel cancer therapeutics (review).一氧化氮供体：新型癌症治疗药物（综述）
Int J Oncol. 2008 Nov;33(5):909-27.
5
The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash.饮食中摄入硝酸盐后血浆亚硝酸盐的增加会因使用抗菌漱口水而显著减弱。
Nitric Oxide. 2008 Dec;19(4):333-7. doi: 10.1016/j.niox.2008.08.003. Epub 2008 Aug 30.
6
Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways.一氧化氮通过依赖和不依赖鸟苷酸环化酶的途径调节基质金属蛋白酶-9的活性。
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16898-903. doi: 10.1073/pnas.0702761104. Epub 2007 Oct 17.
7
Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.生理浓度的一氧化氮作用于翻译机制以增加人乳腺癌细胞的增殖：雷帕霉素哺乳动物靶标/eIF4E途径的参与
Cancer Res. 2007 Jan 1;67(1):289-99. doi: 10.1158/0008-5472.CAN-05-4623.
8
The role of nitric oxide in tumour progression.一氧化氮在肿瘤进展中的作用。
Nat Rev Cancer. 2006 Jul;6(7):521-34. doi: 10.1038/nrc1910.
9
Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2.诱导型一氧化氮合酶结合、S-亚硝基化并激活环氧化酶-2。
Science. 2005 Dec 23;310(5756):1966-70. doi: 10.1126/science.1119407.
10
Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer.诱导型一氧化氮合酶抑制剂的抗癌作用及其与胃癌血管生成的相关性
World J Gastroenterol. 2005 Jul 7;11(25):3830-3. doi: 10.3748/wjg.v11.i25.3830.
Zotero 插件